Rapamycin nanoparticles increase the therapeutic window of engineered interleukin-2 and drive expansion of antigen-specific regulatory T cells for protection against autoimmune disease
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Rapamycin nanoparticles increase the therapeutic window of engineered interleukin-2 and drive expansion of antigen-specific regulatory T cells for protection against autoimmune disease
Authors
Keywords
-
Journal
JOURNAL OF AUTOIMMUNITY
Volume 140, Issue -, Pages 103125
Publisher
Elsevier BV
Online
2023-10-15
DOI
10.1016/j.jaut.2023.103125
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bioengineered particles expand myelin-specific regulatory T cells and reverse autoreactivity in a mouse model of multiple sclerosis
- (2023) Kelly R. Rhodes et al. Science Advances
- Tolerogenic nanoparticles mitigate the formation of anti-drug antibodies against pegylated uricase in patients with hyperuricemia
- (2022) Earl Sands et al. Nature Communications
- Selective activation and expansion of regulatory T cells using lipid encapsulated mRNA encoding a long-acting IL-2 mutein
- (2022) Seymour de Picciotto et al. Nature Communications
- Responses of regulatory and effector T-cells to low-dose interleukin-2 differ depending on the immune environment after allogeneic stem cell transplantation
- (2022) Yusuke Meguri et al. Frontiers in Immunology
- Engineered human cytokine/antibody fusion proteins expand regulatory T cells and confer autoimmune disease protection
- (2022) Derek VanDyke et al. Cell Reports
- Enhancement of liver-directed transgene expression at initial and repeat doses of AAV vectors admixed with ImmTOR nanoparticles
- (2021) Petr O. Ilyinskii et al. Science Advances
- TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease: A Randomized, Double-Blind, Placebo-Controlled Study
- (2021) Ciarán P. Kelly et al. GASTROENTEROLOGY
- Antigen-Specific Regulatory T Cell Therapy in Autoimmune Diseases and Transplantation
- (2021) Claudia Selck et al. Frontiers in Immunology
- Enhancement of the Tolerogenic Phenotype in the Liver by ImmTOR Nanoparticles
- (2021) Petr O. Ilyinskii et al. Frontiers in Immunology
- Development of ImmTOR Tolerogenic Nanoparticles for the Mitigation of Anti-drug Antibodies
- (2020) Takashi Kei Kishimoto Frontiers in Immunology
- Defining the Threshold IL-2 Signal Required for Induction of Selective Treg Cell Responses Using Engineered IL-2 Muteins
- (2020) Aazam Ghelani et al. Frontiers in Immunology
- The Surprising Story of IL-2
- (2020) Abul K. Abbas AMERICAN JOURNAL OF PATHOLOGY
- Regulatory T cells: Master thieves of the immune system
- (2020) Billur Akkaya et al. CELLULAR IMMUNOLOGY
- Persistent IL-2 Receptor Signaling by IL-2/CD25 Fusion Protein Controls Diabetes in NOD Mice by Multiple Mechanisms
- (2020) Natasha C. Ward et al. DIABETES
- An IL-2 mutein engineered to promote expansion of regulatory T cells arrests ongoing autoimmunity in mice
- (2020) Liliane Khoryati et al. Science Immunology
- Regulating the regulators: Is introduction of an antigen-specific approach in regulatory T cells the next step to treat autoimmunity?
- (2020) Ibo Janssens et al. CELLULAR IMMUNOLOGY
- Receptor-gated IL-2 delivery by an anti-human IL-2 antibody activates regulatory T cells in three different species
- (2020) Ufuk Karakus et al. Science Translational Medicine
- Engineering IL-2 to Give New Life to T Cell Immunotherapy
- (2020) Willem W. Overwijk et al. Annual Review of Medicine
- Regulatory T cells mediate specific suppression by depleting peptide–MHC class II from dendritic cells
- (2019) Billur Akkaya et al. NATURE IMMUNOLOGY
- An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
- (2019) Kevan C. Herold et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial
- (2019) Jing He et al. ANNALS OF THE RHEUMATIC DISEASES
- Hybrid insulin peptides are neo-epitopes for CD4 T cells in autoimmune diabetes
- (2019) Rocky L. Baker et al. Current Opinion in Endocrinology Diabetes and Obesity
- A human anti-IL-2 antibody that potentiates regulatory T cells by a structure-based mechanism
- (2018) Eleonora Trotta et al. NATURE MEDICINE
- Effects of ATX-MS-1467 immunotherapy over 16 weeks in relapsing multiple sclerosis
- (2018) Jeremy Chataway et al. NEUROLOGY
- Tolerogenic nanoparticles restore the antitumor activity of recombinant immunotoxins by mitigating immunogenicity
- (2018) Ronit Mazor et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tolerogenic Nanoparticles Induce Antigen-Specific Regulatory T Cells and Provide Therapeutic Efficacy and Transferrable Tolerance against Experimental Autoimmune Encephalomyelitis
- (2018) Robert A. LaMothe et al. Frontiers in Immunology
- Engineering a Single-Agent Cytokine/Antibody Fusion That Selectively Expands Regulatory T Cells for Autoimmune Disease Therapy
- (2018) Jamie B. Spangler et al. JOURNAL OF IMMUNOLOGY
- Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial
- (2018) Michelle Rosenzwajg et al. ANNALS OF THE RHEUMATIC DISEASES
- Treg cells—the next frontier of cell therapy
- (2018) Jeffrey A. Bluestone et al. SCIENCE
- Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration
- (2018) Amine Meliani et al. Nature Communications
- Dominant protection from HLA-linked autoimmunity by antigen-specific regulatory T cells
- (2017) Joshua D. Ooi et al. NATURE
- Regulatory T Cell Specificity Directs Tolerance versus Allergy against Aeroantigens in Humans
- (2016) Petra Bacher et al. CELL
- A roadmap of the generation of neoantigens as targets of the immune system in type 1 diabetes
- (2016) Bart O Roep et al. CURRENT OPINION IN IMMUNOLOGY
- Improving the efficacy and safety of biologic drugs with tolerogenic nanoparticles
- (2016) Takashi K. Kishimoto et al. Nature Nanotechnology
- Antigen exposure shapes the ratio between antigen-specific Tregs and conventional T cells in human peripheral blood
- (2016) Laura F. Su et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus
- (2015) Caroline von Spee-Mayer et al. ANNALS OF THE RHEUMATIC DISEASES
- Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells
- (2015) Charles J.M. Bell et al. JOURNAL OF AUTOIMMUNITY
- CD4+CD25+ Foxp3+ Regulatory T Cells Protect against T Cell-Mediated Fulminant Hepatitis in a TGF- -Dependent Manner in Mice
- (2014) H.-X. Wei et al. JOURNAL OF IMMUNOLOGY
- Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance
- (2014) Roberto A. Maldonado et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout
- (2014) Peter E Lipsky et al. ARTHRITIS RESEARCH & THERAPY
- Immune responses to AAV vectors: overcoming barriers to successful gene therapy
- (2013) F. Mingozzi et al. BLOOD
- Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and Immunotherapy
- (2013) Wei Liao et al. IMMUNITY
- Do MHCII-Presented Neoantigens Drive Type 1 Diabetes and Other Autoimmune Diseases?
- (2013) P. Marrack et al. Cold Spring Harbor Perspectives in Medicine
- Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs -Cell Function
- (2012) S. A. Long et al. DIABETES
- Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
- (2011) John Koreth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhancement of antigen-specific Treg vaccination in vivo
- (2010) C. Daniel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Autoantigens in systemic autoimmunity: critical partner in pathogenesis
- (2009) A. Rosen et al. JOURNAL OF INTERNAL MEDICINE
- Immunity to Citrullinated Proteins in Rheumatoid Arthritis
- (2008) Lars Klareskog et al. Annual Review of Immunology
- Combination of rapamycin and IL-2 increases de novo induction of human CD4+CD25+FOXP3+ T cells
- (2008) S. Alice Long et al. JOURNAL OF AUTOIMMUNITY
- The Biology of Interleukin-2
- (2007) Thomas R. Malek Annual Review of Immunology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now